CURLF
Price
$3.37
Change
+$0.17 (+5.31%)
Updated
Aug 28 closing price
Capitalization
2.5B
73 days until earnings call
GLASF
Price
$8.33
Change
+$0.09 (+1.09%)
Updated
Aug 28 closing price
Capitalization
658.44M
Interact to see
Advertisement

CURLF vs GLASF

Header iconCURLF vs GLASF Comparison
Open Charts CURLF vs GLASFBanner chart's image
Curaleaf
Price$3.37
Change+$0.17 (+5.31%)
Volume$3.09M
Capitalization2.5B
Glass House Brands
Price$8.33
Change+$0.09 (+1.09%)
Volume$549.5K
Capitalization658.44M
CURLF vs GLASF Comparison Chart in %
Loading...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLASF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CURLF vs. GLASF commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURLF is a Buy and GLASF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (CURLF: $3.37 vs. GLASF: $8.33)
Brand notoriety: CURLF and GLASF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CURLF: 171% vs. GLASF: 124%
Market capitalization -- CURLF: $2.58B vs. GLASF: $651.32M
CURLF [@Pharmaceuticals: Generic] is valued at $2.58B. GLASF’s [@Pharmaceuticals: Generic] market capitalization is $651.32M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CURLF’s FA Score shows that 0 FA rating(s) are green whileGLASF’s FA Score has 0 green FA rating(s).

  • CURLF’s FA Score: 0 green, 5 red.
  • GLASF’s FA Score: 0 green, 5 red.
According to our system of comparison, CURLF is a better buy in the long-term than GLASF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CURLF’s TA Score shows that 3 TA indicator(s) are bullish while GLASF’s TA Score has 7 bullish TA indicator(s).

  • CURLF’s TA Score: 3 bullish, 4 bearish.
  • GLASF’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, GLASF is a better buy in the short-term than CURLF.

Price Growth

CURLF (@Pharmaceuticals: Generic) experienced а +17.83% price change this week, while GLASF (@Pharmaceuticals: Generic) price change was +4.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Reported Earning Dates

CURLF is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CURLF($2.5B) has a higher market cap than GLASF($658M). CURLF YTD gains are higher at: 116.026 vs. GLASF (43.603). CURLF has higher annual earnings (EBITDA): 220M vs. GLASF (49M). CURLF has more cash in the bank: 102M vs. GLASF (40.7M). GLASF has less debt than CURLF: GLASF (72.8M) vs CURLF (843M). CURLF has higher revenues than GLASF: CURLF (1.29B) vs GLASF (222M).
CURLFGLASFCURLF / GLASF
Capitalization2.5B658M380%
EBITDA220M49M449%
Gain YTD116.02643.603266%
P/E RatioN/A513.07-
Revenue1.29B222M579%
Total Cash102M40.7M251%
Total Debt843M72.8M1,158%
FUNDAMENTALS RATINGS
CURLF vs GLASF: Fundamental Ratings
CURLF
GLASF
OUTLOOK RATING
1..100
2528
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3437
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CURLF's Valuation (52) in the null industry is somewhat better than the same rating for GLASF (94). This means that CURLF’s stock grew somewhat faster than GLASF’s over the last 12 months.

CURLF's Profit vs Risk Rating (100) in the null industry is in the same range as GLASF (100). This means that CURLF’s stock grew similarly to GLASF’s over the last 12 months.

CURLF's SMR Rating (100) in the null industry is in the same range as GLASF (100). This means that CURLF’s stock grew similarly to GLASF’s over the last 12 months.

CURLF's Price Growth Rating (34) in the null industry is in the same range as GLASF (37). This means that CURLF’s stock grew similarly to GLASF’s over the last 12 months.

CURLF's P/E Growth Rating (100) in the null industry is in the same range as GLASF (100). This means that CURLF’s stock grew similarly to GLASF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CURLFGLASF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
Bearish Trend about 1 month ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLASF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTGX27.010.08
+0.30%
Artisan Global Value Investor
FNORX66.20N/A
N/A
Fidelity Nordic
MWOCX50.07N/A
N/A
MFS Global Growth C
GLNMX25.34N/A
N/A
MFS Global New Discovery R4
JGVVX47.37N/A
N/A
JPMorgan Growth Advantage R6

CURLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CURLF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURLF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURLF
1D Price
Change %
CURLF100%
+5.20%
GTBIF - CURLF
82%
Closely correlated
-0.59%
TCNNF - CURLF
80%
Closely correlated
+0.89%
VRNOF - CURLF
78%
Closely correlated
-2.37%
CRLBF - CURLF
76%
Closely correlated
+4.01%
TSNDF - CURLF
75%
Closely correlated
+0.89%
More

GLASF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLASF
1D Price
Change %
GLASF100%
+1.08%
TSNDF - GLASF
63%
Loosely correlated
+0.89%
GTBIF - GLASF
62%
Loosely correlated
-0.59%
TCNNF - GLASF
60%
Loosely correlated
+0.89%
VRNOF - GLASF
58%
Loosely correlated
-2.37%
CURLF - GLASF
57%
Loosely correlated
+5.20%
More